Adrenergic mechanisms in multiple sclerosis: the neuro–immune connection?
Marco Cosentino(University of Insubria), Gianmario Frigo(University of Insubria), María Trojano(University of Bari Aldo Moro), Maurizio Giorelli(ASL Roma), Sergio Lecchini(University of Insubria), Emanuela Rasini(University of Insubria), Paolo Livrea(University of Bari Aldo Moro), Marco Ferrari(University of Insubria), Giancarlo Comi(University of Milan), Mauro Zaffaroni(Associazione Italiana Sclerosi Multipla), R Bombelli(University of Insubria), Franca Marino(University of Insubria)
Cited by 4
Related Papers
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Multiple Sclerosis Severity Score
|Neurology|2005|959
Multiple sclerosis progression: time for a new mechanism-driven framework
|The Lancet Neurology|2022|624
Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomised multicentre study (INCOMIN)
|The Lancet|2002|552
Multiple sclerosis in childhood: clinical features of 149 cases
|Multiple Sclerosis Journal|1997|309